Global X Japan Co. Ltd. Has $17.90 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Global X Japan Co. Ltd. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,025 shares of the medical equipment provider’s stock after selling 2,924 shares during the quarter. Intuitive Surgical accounts for approximately 1.5% of Global X Japan Co. Ltd.’s holdings, making the stock its 18th biggest position. Global X Japan Co. Ltd.’s holdings in Intuitive Surgical were worth $17,900,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Aaron Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after buying an additional 19 shares during the last quarter. Evergreen Capital Management LLC raised its holdings in Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after acquiring an additional 20 shares in the last quarter. Rise Advisors LLC lifted its position in shares of Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after acquiring an additional 20 shares during the period. Pinnacle Bancorp Inc. grew its holdings in shares of Intuitive Surgical by 4.1% during the 2nd quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after purchasing an additional 21 shares in the last quarter. Finally, Vertex Planning Partners LLC increased its position in shares of Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after purchasing an additional 21 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In other news, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $435,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Citigroup lowered shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and decreased their target price for the company from $650.00 to $635.00 in a research report on Thursday, December 11th. HSBC increased their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Piper Sandler lifted their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Finally, Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $611.08.

Intuitive Surgical Trading Down 0.4%

NASDAQ ISRG opened at $577.34 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a 50 day moving average of $547.18 and a 200-day moving average of $505.91. The firm has a market cap of $206.96 billion, a price-to-earnings ratio of 76.37, a PEG ratio of 5.33 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the company earned $1.84 EPS. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.